Insider Transactions in Q1 2022 at Hookipa Pharma Inc. (HOOK)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Jorn Aldag Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
47,824
+47.93%
|
$143,472
$3.0 P/Share
|
|
Feb 01
2022
|
Reinhard Kandera Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,056
+46.62%
|
$42,168
$3.0 P/Share
|
|
Feb 01
2022
|
Igor Matushansky Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,933
+12.97%
|
$44,799
$3.0 P/Share
|
|
Feb 01
2022
|
Roman Necina Chief Operations Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,892
+46.43%
|
$38,676
$3.0 P/Share
|
|
Feb 01
2022
|
Christine D. Baker Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,658
+45.81%
|
$40,974
$3.0 P/Share
|
|
Feb 01
2022
|
Klaus Orlinger Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,188
+46.9%
|
$27,564
$3.0 P/Share
|